Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O5ZB
|
|||
| Former ID |
DIB004110
|
|||
| Drug Name |
Ilodecakin
|
|||
| Synonyms |
Prevascar; Ilodecakin, Renovo; Recombinant IL-10 (scarring), Renovo
Click to Show/Hide
|
|||
| Indication | Sarcoidosis [ICD-11: 4B20.5; ICD-10: D86.3] | Phase 2 | [1] | |
| Company |
Renovo Group plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00984646) Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10). U.S. National Institutes of Health. | |||
| REF 2 | Ilodecakin. Schering-Plough Corp. IDrugs. 1999 Oct;2(10):1045-58. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.